Clinical trial · Interventional
Nurse-led Transitional Care to Improve Symptom Management in Childhood Cancer Survivors
A Nurse-facilitated Interdisciplinary Transitional Care Programme for Childhood Cancer Survivors and Their Parents to Improve Symptom Management: a Feasibility Randomised Waitlist-controlled Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to evaluate the feasibility and preliminary effectiveness of a nurse-facilitated interdisciplinary transitional care programme, based on the Omaha system, for Chinese childhood cancer survivors (CCSs) and their parents in Hong Kong. Investigators will conduct a two-arm, randomized waitlist-controlled trial at the Hong Kong Children's Hospital, the only local center for CCS follow-up. Sixty-eight dyads (CCS aged 13-18 and a parent) will be randomized to either the 12-week nurse-led intervention or usual care. The intervention includes an initial face-to-face assessment and regular follow-ups via Zoom, focusing on symptom management, health education, and self-care empowerment, with referrals to other professionals as needed. The control group receives standard discharge care and educational materials, and will be offered the intervention after data collection. Outcomes will be assessed at baseline, and 3 and 6 months post-intervention, including symptom management, quality of life, caregiver burden, self-efficacy, and emergency department visits. Feasibility will be evaluated by recruitment, retention, attendance, and data completeness rates. If effective, this programme could improve transitional care and symptom management for CCSs and their families, and inform clinical practice and policy in Hong Kong and beyond.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pediatric Cancer | Childhood Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Counseling based on Omaha system | Other | — | UNRESOLVED |
| Usual Care | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention group
- interventionNames
- Other: Counseling based on Omaha system
- type
- OTHER
- label
- Wait-list control group
- interventionNames
- Other: Counseling based on Omaha system
- Other: Usual Care
Primary outcomes (9)
- measure
- Screening rate
- timeFrame
- Baseline
- description
- Number of dyads screened divided by number of dyads available for screening.
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 13 Years
- Maximum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria for CCSs: * aged between 13 and 18 years * diagnosed with any cancer * completion of active cancer treatment within a month * communicate in Chinese Inclusion Criteria for parents: * mother or father who has a significant caregiving role in the child's life * could participate in the intervention at the same time as their child * communicate in Chinese * have an electronic device to access zoom Exclusion Criteria for CCSs: * cognitive impairment * social and/or behavioural problem * have terminal cancer * participate in any similar intervention Exclusion Criteria for parents: * severe emotional problems * participate in any similar intervention
References
Publications (0)
Data not yet available